Payments linked to higher odds of doctors prescribing certain cancer drugs

ScienceDaily - Health and Medicine News

Researchers show that when physicians had to choose between multiple, on-patent drugs for metastatic kidney cancer and chronic myeloid leukemia, they were more likely to prescribe drugs from companies they had received general payments from.